Chapter 8 of the FAO/WHO expert consultation on human vitamin and mineral requirements reviews vitamin D metabolism, its role in calcium and phosphate homeostasis, and its importance for bone health. It discusses populations at risk of deficiency, including infants, adolescents and older adults, as well as pregnancy and lactation. The chapter examines evidence used to estimate vitamin D requirements, plasma 25-OH-D as a status indicator, factors affecting skin synthesis, age-specific recommended nutrient intakes, toxicity and future research needs. It includes supplementation trial summaries and references.
Free preview text
The first 5 pages, shown as text so search engines and readers can find this document.
Page 1
FAO/WHO expert consultation on human vitamin and mineral requirements 109
Chapter 8
Vitamin D
Summary of the role of vitamin D in human metabolic processes
itamin D is required to maintain normal blood levels of calcium and phosphate, that
are in turn needed for the normal mineralisation of bone, muscle contraction, nerve
conduction, and general cellular function in all cells of the body. Vitamin D achieves
this after its conversion to the active form 1,25-dihydroxyvitamin D [1,25-(OH)2D], or
calcitriol. This active form regulates the transcription of a number of vitamin D–dependent
genes coding for calcium-transporting proteins and bone matrix proteins.
Vitamin D also modulates the transcription of cell cycle proteins, that decrease cell
proliferation and increase cell differentiation of a number of specialised cells of the body
(e.g., osteoclastic precursors, enterocytes, keratinocytes, etc.). This property may explain the
actions of vitamin D in bone resorption, intestinal calcium transport, and skin. Vitamin D also
possesses immuno-modulatory properties that may alter responses to infections in vivo. The
cell differentiating and immuno-modulatory properties underlie the reason why vitamin D
derivatives are now used successfully in the treatment of psoriasis and other skin disorders.
Clinical assays measure 1,25-(OH)2D2 and 1,25-(OH)2D3, collectively called
1,25-(OH)2D. Similarly, calcidiol is measured as 25-OH-D but it is a mixture of 25-OH-D2
and 25-OH-D3. For the purposes of this document, 1,25-(OH)2D and 25-OH-D will be used to
refer to calcitriol and calcidiol, respectively.
Overview of the role of vitamin D
Vitamin D, a seco-steroid, can either be made in the skin from a cholesterol-like precursor (7-
dehydrocholesterol) by exposure to sunlight or can be provided pre-formed in the diet (1). The
version made in the skin is referred to as vitamin D3 whereas the dietary form can be vitamin
D3 or a closely related molecule of plant origin known as vitamin D2 . Because vitamin D can
be made in the skin, it should not strictly be called a vitamin, and some nutritional texts refer
to the substance as a prohormone and to the two forms as cholecalciferol (D3) or
ergocalciferol (D2).
From a nutritional perspective, the two forms are metabolised similarly in humans, are
equal in potency, and can be considered equivalent. It is now firmly established that vitamin
D3 is metabolised first in the liver to 25-hydroxyvitamin-D (25-OH-D or calcidiol) (2) and
subsequently in the kidneys to 1,25-(OH)2D (3) to produce a biologically active hormone. The
1,25-(OH)2D, like all vitamin D metabolites, is present in the blood complexed to vitamin D
binding protein, a specific α-globulin. The 1,25-(OH)2D is believed to act on target cells
similarly to the way a steroid hormone would act. Free hormone crosses the plasma
membrane and interacts with a specific nuclear receptor known as the vitamin D receptor, a
DNA-binding, zinc-finger protein with a molecular weight of 55,000 (4). This ligand-receptor
complex binds to a specific vitamin D–responsive element and, with associated transcription
factors (e.g., retinoid X receptor), enhances transcription of mRNAs which code for calcium-
transporting proteins, bone matrix proteins, or cell cycle–regulating proteins (5). As a result of
these processes ,1,25-(OH)2D stimulates intestinal absorption of calcium and phosphate and
mobilises calcium and phosphate by stimulating bone resorption (6). These functions serve
V
Page 2
110 Chapter 8: Vitamin D
the common purpose of restoring blood levels of calcium and phosphate to normal when
concentrations of the two ions are low.
Lately, interest has focused on other cellular actions of 1,25-(OH)2D. With the
discovery of 1,25-(OH)2D receptors in many classical non-target tissues such as brain, various
bone marrow–derived cells, skin, thymus, etc. (7), the view has been expressed that
1,25-(OH)2D induces fusion and differentiation of macrophages (8, 9). This effect has been
widely interpreted to mean that the natural role of 1,25-(OH)2D is to induce
osteoclastogenesis from colony forming units–granulatory monocytes in the bone marrow.
The 1,25-(OH)2D also suppresses interleukin 2 production in activated T lymphocytes (10,
11), an effect which suggests the hormone might play a role in immuno-modulation in vivo.
Other tissues (e.g., skin) are directly affected by exogenous administration of vitamin D,
though the physiologic significance of these effects is poorly understood. The pharmacologic
effects of 1,25-(OH)2D are profound and have resulted in the development of vitamin D
analogues, that are approved for use in hyper-proliferative conditions such as psoriasis (12).
In calcium homeostasis 1,25-(OH)2D works in conjunction with parathyroid hormone
(PTH) to produce its beneficial effects on the plasma levels of ionised calcium and phosphate
(5, 13). The physiologic loop (Figure 10) starts with calcium sensing by the calcium receptor
of the parathyroid gland (14). When the level of ionised calcium in plasma falls, PTH is
secreted by the parathyroid gland and stimulates the tightly regulated renal enzyme 25-OH-D-
1-α-hydroxylase to make more 1,25-(OH)2D from the large circulating pool of 25-OH-D. The
resulting increase in 1,25-(OH)2D (with the rise in PTH) causes an increase in calcium
transport within the intestine, bone, and kidney. All these events raise plasma calcium levels
back to normal, that in turn is sensed by the calcium receptor of the parathyroid gland. The
further secretion of PTH is turned off not only by the feedback action of calcium, but also by
a short feedback loop involving 1,25-(OH)2D directly suppressing PTH synthesis in the
parathyroid gland (not shown in figure).
Figure 10
Calcium homeostasis
Source: Adapted from Jones et al. (13).
Page 3
FAO/WHO expert consultation on human vitamin and mineral requirements 111
Although this model oversimplifies the events involved in calcium homeostasis it is
easy to see from it that sufficient 25-OH-D must be available to provide adequate 1,25-
(OH)2D synthesis and hence an adequate level of plasma calcium and that vitamin D
deficiency will result in inadequate 25-OH-D and 1,25-(OH)2D synthesis, inadequate calcium
homeostasis, and a constantly elevated PTH level (termed: secondary hyperparathyroidism).
It becomes evident from this method of presentation of the role of vitamin D that the
nutritionist can focus on the plasma levels of 25-OH-D and PTH to gain an insight into
vitamin D status. Not shown but also important is the endpoint of the physiologic action of
vitamin D, namely adequate plasma calcium and phosphate ions, that provide the raw
materials for bone mineralisation.
Populations at risk for vitamin D deficiency
Infants
Infants constitute a population at risk for vitamin D deficiency because of relatively large
vitamin D needs brought about by their high rate of skeletal growth. At birth, infants have
acquired in utero the vitamin D stores that must carry them through the first months of life. A
recent survey of French neonates revealed that 64 percent had 25-OH-D values below 30
nmol/l, the lower limit of the normal range (15). Breast-fed infants are particularly at risk
because of the low concentrations of vitamin D in human milk (16). This problem is further
compounded in some infants fed human milk by a restriction in exposure to ultraviolet (UV)
light for seasonal, latitudinal, cultural, or social reasons. Infants born in the autumn months at
extremes of latitude are particularly at risk because they spend the first 6 months of their life
indoors and therefore have little opportunity to synthesise vitamin D in their skin during this
period. Consequently, although vitamin D deficiency is rare in developed countries, sporadic
cases of rickets are still being reported in many northern cities but almost always in infants
fed human milk (17-20).
Infant formulas are supplemented with vitamin D at levels ranging from 40
international units (IUs) or 1 μg /418.4 kJ to 100 IU or 2.5 μg /418.4 kJ, that provide
approximately between 6 μg and 15 μg of vitamin D, respectively. These amounts of dietary
vitamin D are sufficient to prevent rickets.
Adolescents
Another period of rapid growth of the skeleton occurs at puberty and increases the need not
for the vitamin D itself, but for the active form 1,25-(OH)2D. This need results from the
increased conversion of 25-OH-D to 1,25-(OH)2D in adolescents (21). Furthermore, unlike
infants, adolescents are usually outdoors and therefore usually are exposed to UV light
sufficient for synthesising vitamin D for their needs. Excess production of vitamin D in the
summer and early fall months is stored mainly in the adipose tissue (22) and is available to
sustain high growth rates in the winter months that follow. Insufficient vitamin D stores
during these periods of increased growth can lead to vitamin D insufficiency (23).
Elderly
Over the past 20 years, clinical research studies of the basic biochemical machinery handling
vitamin D have suggested an age-related decline in many key steps of vitamin D action (24)
including rate of skin synthesis, rate of hydroxylation leading to activation to the hormonal
form, and response of target tissues (e.g., bone) as well as reduced skin exposure (25). Not
surprisingly a number of independent studies from around the world have shown that there
appears to be vitamin D deficiency in a subset of the elderly population, as characterised by
low blood levels of 25-OH-D coupled with elevations of plasma PTH and alkaline
Page 4
112 Chapter 8: Vitamin D
phosphatase (26). There is evidence that this vitamin D deficiency contributes to declining
bone mass and increases the incidence of hip fractures (27). Although some of these studies
may exaggerate the extent of the problem by focusing on institutionalised individuals or
in-patients with decreased sun exposures, in general they have forced health professionals to
re-address the intakes of this segment of society and look at potential solutions to correct the
problem. Several groups have found that modest increases in vitamin D intakes (between 10
and 20 μg/day) reduce the rate of bone loss and the fracture rate (25-29).
These findings have led agencies and researchers to suggest an increase in recommended
vitamin D intakes for the elderly from the suggested 2.5–5 μg /day to a value that is able to
maintain normal 25-OH-D levels in the elderly, such as 10–15 μg/day. This vitamin D intake
results in lower rates of bone loss and is suggested for the middle-aged (50–70 years) and
old-aged (>70 years) populations (33). The increased requirements are justified mainly on the
grounds of the reduction in skin synthesis of vitamin D, a linear reduction occurring in both
men and women, that begins with the thinning of the skin at age 20 years (24).
Pregnancy and lactation
Elucidation of the changes in calciotropic hormones occurring during pregnancy and lactation
has revealed a role for vitamin D in the former but probably not the latter. Even in pregnancy,
the changes in vitamin D metabolism which occur, namely an increase in the maternal plasma
levels of 1,25-(OH)2D (34) due to a putative placental synthesis of the hormone (35), do not
seem to impinge greatly on the maternal vitamin D requirements. The concern that modest
vitamin D supplementation might be deleterious to the foetus is not justified. Furthermore,
because transfer of vitamin D from mother to foetus is important for establishing the
newborn’s growth rate, the goal of ensuring adequate vitamin D status with conventional
prenatal vitamin D supplements probably should not be discouraged.
In lactating women there appears to be no direct role for vitamin D because increased
calcium needs are regulated by PTH-related peptide (36, 37), and recent studies have failed to
show any change in vitamin D metabolites during lactation (38, 39). As stated above, the
vitamin D content of human milk is low (16). Consequently, there is no great drain on
maternal vitamin D reserves either to regulate calcium homeostasis or to supply the need of
human milk. Because human milk is a poor source of vitamin D, rare cases of nutritional
rickets are still found, but these are almost always in breast-fed babies deprived of sunlight
exposure (17-20). Furthermore, there is little evidence that increasing calcium or vitamin D
supplements to lactating mothers results in an increased transfer of calcium or vitamin D in
milk (38). Thus, the current thinking, based on a clearer understanding of the role of vitamin
D in lactation, is that there is little purpose in recommending additional vitamin D for
lactating women. The goal for mothers who breast-feed their infants seems to be merely to
ensure good nutrition and sunshine exposure in order to ensure normal vitamin D status
during the perinatal period.
Page 5
Table 19
Randomised, controlled trials with dietary vitamin D supplements
Reference Study Group n b
Age
(years)
Mean SD Regimen
Duration
(years) Resultsa
Dawson-Hughes et al., 1991
(28)
Chapuy et al., 1992 (29)
Chapuy et al., 1994 (30) c
Dawson-Hughes et al., 1995
(31)
Lips et al., 1996 (32)
Healthy, post-menopausal women
living independently
Healthy, elderly women living in
nursing homes or in apartments
for the elderly
Healthy post-menopausal women
living independently
Healthy elderly living
independently, in nursing homes,
or in apartments for the elderly
249
3270
261
2578
(1916-Fem.)
(662-Male)
62
84
64
80
0.5
6
5
6
10 μg vitamin D
+
400 mg calcium
20 μg vitamin D
+
1200 mg calcium
2.5 μg or 17.5 μg
vitamin D
+
500 mg calcium
10 μg vitamin D
1.0
1.5
3.0
2.0
Reduced late wintertime bone
loss from vertebrae; net spine
BMD; no change in whole-body
BMD.
Hip fractures 43% ; non-vertebral
fractures 32%;
in subset (n=56), BMD of
proximal femur 2.7% in vitamin
D group and 4.6% in placebo
group.
Hip fractures 29%; non-vertebral
fractures 24%.
Loss of BMD from femoral neck
lower in 17.5μg group (-1.06%)
than in 2.5 μg group (-2.54%); no
difference in BMD at spine.
No difference in fracture
incidence; in subset (n=248) of
women from nursing homes,
BMD 2.3% after 2 years.
a ↑ Increase; ↓ decrease.
b Number of subjects enrolled in the study.
c Same study as Chapuy et al. (29) after further 1.5 years of treatment.
Source: Adapted with permission from Shearer (25).
Chapter 8: Vitamin D: summary, contents and background
This guide helps you understand the scope of Chapter 8: Vitamin D before or alongside reading the original document. It is based on the catalogue record, credited creator, source, classification and topics shown on this page. It does not replace the original work and does not invent claims about passages that Doxxly cannot verify.
Summary and overview
Chapter 8: Vitamin D is a 12-page documentcredited to Gideon S. Yarrow. Chapter 8 of the FAO/WHO expert consultation on human vitamin and mineral requirements reviews vitamin D metabolism, its role in calcium and phosphate homeostasis, and its importance for bone health. It discusses populations at risk of deficiency, including infants, adolescents and older adults, as well as pregnancy and lactation. The chapter examines evidence used to estimate vitamin D requirements, plasma 25-OH-D as a status indicator, factors affecting skin synthesis, age-specific recommended nutrient intakes, toxicity and future research needs. It includes supplementation trial summaries and references. It appears in the Health & Fitness collection, which groups it with other material that readers may use for comparison and further study.
The item can be approached in several ways. A reader looking for a quick orientation can begin with the free five-page preview, inspect the page structure and use the metadata to judge relevance. Someone undertaking deeper research can work through the complete file, search its indexed text, record useful page references and compare its treatment of Vitamin D, Human nutrition, Vitamin requirements, Calcium homeostasis, Bone health, Vitamin D deficiency, Recommended nutrient intakes, Vitamin D toxicity with the related resources linked below.
Rather than reducing the work to a single claim, this page treats it as a source that should be read in context. The title, creator, publication source, licence and format all help explain what kind of evidence it may offer. Readers should distinguish the original author's statements from Doxxly's catalogue description, and should cite the original edition when using the material in academic, professional or published work.
Key topics and reader takeaways
The catalogue connects this document with Vitamin D, Human nutrition, Vitamin requirements, Calcium homeostasis, Bone health, Vitamin D deficiency, Recommended nutrient intakes, Vitamin D toxicity. These terms offer practical entry points rather than a substitute for close reading. Start by identifying the definitions, examples, arguments, tables or visual explanations attached to each topic. Then note where the creator draws connections, makes distinctions or moves from background material to a conclusion, recommendation, calculation or narrative development.
A useful reading method is to separate description from interpretation. First record what the item actually presents: names, headings, figures, formulas, quotations or stated propositions. Next consider why those details matter within the whole work. Finally compare them with another source from the same subject area. This process helps turn a long digital file into evidence that can be evaluated rather than merely skimmed.
Table of contents and reading guide
The following is an editorial content guide based on the verified catalogue topics. It is not represented as the original author's formal table of contents. Use it to organise notes while moving through the 12 pages in the player.
Part 1
Vitamin D
Use this section of the reading guide to identify how Vitamin D appears in Chapter 8: Vitamin D, note important terms, and connect the subject to the wider purpose of the work.
Part 2
Human nutrition
Use this section of the reading guide to identify how Human nutrition appears in Chapter 8: Vitamin D, note important terms, and connect the subject to the wider purpose of the work.
Part 3
Vitamin requirements
Use this section of the reading guide to identify how Vitamin requirements appears in Chapter 8: Vitamin D, note important terms, and connect the subject to the wider purpose of the work.
Part 4
Calcium homeostasis
Use this section of the reading guide to identify how Calcium homeostasis appears in Chapter 8: Vitamin D, note important terms, and connect the subject to the wider purpose of the work.
Part 5
Bone health
Use this section of the reading guide to identify how Bone health appears in Chapter 8: Vitamin D, note important terms, and connect the subject to the wider purpose of the work.
Part 6
Vitamin D deficiency
Use this section of the reading guide to identify how Vitamin D deficiency appears in Chapter 8: Vitamin D, note important terms, and connect the subject to the wider purpose of the work.
Part 7
Recommended nutrient intakes
Use this section of the reading guide to identify how Recommended nutrient intakes appears in Chapter 8: Vitamin D, note important terms, and connect the subject to the wider purpose of the work.
Part 8
Vitamin D toxicity
Use this section of the reading guide to identify how Vitamin D toxicity appears in Chapter 8: Vitamin D, note important terms, and connect the subject to the wider purpose of the work.
When a heading in the original differs from this guide, follow the original heading in your citation. Page numbers can also vary between editions. Doxxly's direct page field is useful for navigation, but formal references should include the title, creator, source and edition details available in the file itself.
About Gideon S. Yarrow
Doxxly credits Gideon S. Yarrow as the author or creator of Chapter 8: Vitamin D. This page does not add an unverified biography, job title or institutional affiliation. The attribution is preserved so readers can distinguish the creator from the hosting library and follow the original record when an external author link is available.
Author context matters because a work reflects a particular purpose, audience and point of view. Before relying on the material, consider what the creator set out to explain, when the source was produced and whether later research or revised guidance should also be consulted. For literature and philosophy, compare translations and editions; for technical material, check whether a newer version has superseded the one shown here.
About the source organisation
The recorded source for this item is fao.org. Doxxly provides access and discovery tools but does not claim to be the original publisher unless explicitly stated. Source links, creator attribution and the recorded Publicly available file collected for editorial review licence are displayed to help readers assess provenance and permitted use.
Provenance is especially important for reports, standards, presentations and working spreadsheets. Check the original source for amendments, supporting files and current policy. A trustworthy research workflow keeps the source URL with any notes or downloaded copy, verifies important figures against the original, and avoids treating an archived document as automatically current.
Begin with the title and opening pages, then use the guide above to decide whether to read sequentially or move to a particular topic. The Doxxly player provides previous and next navigation, a direct page field, zoom steps, fit-to-width and fit-to-page modes, rotation and fullscreen. These controls are useful when a page contains small type, a wide table, an image, a scanned layout or a dense sequence of notes.
The first five pages are open to every visitor. A plan unlocks the complete item and full-document search. Search is best used for distinctive names, technical terms or short phrases; broad words can produce too many possible contexts. When you find a useful passage, read the surrounding pages so that a sentence, chart or formula is not separated from its explanation.
If downloading is enabled, members can obtain the original PDF file. Keep the original format when formulas, slide sequencing, pagination or layout carries meaning. Respect the Publicly available file collected for editorial review terms displayed on this page, and use the rights-report link if you believe the attribution or availability needs review.
Research questions to consider
As you read Chapter 8: Vitamin D, ask which audience the creator addresses, what problem or idea organises the work, what evidence is presented, and which assumptions remain unstated. Note whether important terms are defined consistently and whether examples represent a broader pattern or a narrow case. For quantitative material, record units, time periods, formulas and data sources. For interpretive material, separate the creator's language from your own summary.
A second set of questions concerns relevance today. Which parts remain durable, which depend on their historical or institutional setting, and what would need confirmation from a newer source? Following the tags and the Health & Fitness collection can reveal useful comparisons. Agreement between sources can strengthen confidence, while disagreement can point to changing definitions, methods, evidence or priorities.
Finally, decide what you need from the item: background knowledge, a quotation, a worked example, a model, a visual explanation or a starting bibliography. That purpose should guide the depth of reading and the notes you keep. Doxxly helps locate and navigate the source; careful interpretation remains the reader's responsibility.